3 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 2 | Terminated 2 |
Follow Brain Edema: new trials by email Literature Review of Brain Edema trials Research Report on Brain Edema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593) Glyburide, Placebo - Cerebral Edema, Brain Metastases | Phase 1 / Phase 2 | Terminated | University of Alabama at Birmingham | 1 | 2017-08-16 | 2022-09-21 |
| Tolerability Study of Xerecept® in Pediatric Patients XERECEPT - Brain Edema, Brain Tumor | Phase 1 / Phase 2 | Terminated | Celtic Pharma Development Services | 15 | 2010-06-01 | 2013-07-30 |
| Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme Boswellia serrata extract, cyanocobalamin - Brain and Central Nervous System Tumors, Cerebral Edema | Phase 2 | Terminated | Ali Altunkaya | 12 | 2004-09-01 | 2019-04-30 |
Brain Neoplasms (2) · Astrocytoma (1) · Central Nervous System Neoplasms (1) · Edema (1) · Glioblastoma (1) · Gliosarcoma (1) · Oligodendroglioma (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Nervous System Diseases (3) · Nervous System Neoplasms (3) · Central Nervous System Neoplasms (2) · Glioma (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1) · Pathological Conditions, Signs and Symptoms (1)
Corticotropin-Releasing Hormone (1) · Frankincense (1) · Glyburide (1) · Vitamin B 12 (1)
Ali Altunkaya (1) · Celtic Pharma Development Services (1) · University of Alabama at Birmingham (1)
United States (3)
Glen Stevens, DO, PhD (1) · Stewart Goldman, MD (1)
R21CA107277 (1)